Inhibitory activity of quercetin and its metabolite on lipopolysaccharide-induced activation of macrophage U937 cells

Food and Chemical Toxicology

Volumn 47, Issue 4, 2009, Pages 809-812

  Okoko, Tebekeme ^a   Oruambo, Ibiba Felix ^b  

^a NIGER DELTA UNIVERSITY   (Nigeria)

^b RIVERS STATE UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Nigeria)

Author keywords

3 O methyl quercetin; Catalase; Macrophage; Nitric oxide; Quercetin

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CATALASE; INTERLEUKIN 1; INTERLEUKIN 6; NITRIC OXIDE; PHORBOL 13 ACETATE 12 MYRISTATE; QUERCETIN; QUERCETIN 3 METHYL ETHER; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL LEVEL; CELL STRAIN U937; CYTOKINE PRODUCTION; DRUG ACTIVITY; ENZYME ACTIVITY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOMODULATION; INCUBATION TIME; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION INHIBITION; METHYLATION; PROTEIN SYNTHESIS INHIBITION; SUPERNATANT;

HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; QUERCETIN; TETRADECANOYLPHORBOL ACETATE; U937 CELLS;

EID: 61349162255     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.01.013     Document Type: Article

References (26)

1. Aebi H. Catalase in vitro. Meth. Enzymol. 105 (1984) 121-126
2. Angeloni C., Spencer J.P., Leonani E., Biagi P.L., and Hrelia S. Role of quercetin and its in vivo metabolites in protecting H9c2 cells against oxidative stress. Biochimie 89 (2007) 73-82
3. Becker L.B. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc. Res. 61 (2004) 461-470
4. Boyer J., Brown D., and Liu R.H. Uptake of quercetin and quercetin 3-glycoside from whole onion and apple peel extract by caco-2 monolayers. J. Agric. Food Chem. 52 (2004) 7172-7179
5. Chabrier P.E., Demerle-Pallardy C., and Auguet M. Nitric oxide synthases; targets for therapeutic strategies in neurological diseases. Cell Mol. Life Sci. 55 (1999) 1029-1035
6. Chen C., and Kong A.N.T. Dietary chemopreventive compounds and ARE/EpRE signalling. Free Rad. Biol. Med. 36 (2004) 1505-1516
7. Dufresne C.J., and Farnsworth E.R. A review of the latest findings on health promoting properties in tea. J. Nutr. Biochem. 12 (2001) 404-421
8. Goldsby A.G., Kindt T.J., Osborn B.O., and Kuby J. Hypersensitivity reactions. Immunology. fifth ed. (2003), Freeman and Company 381-382
9. Hertog M.G., Feskins E.J., Hollman P.C., Katan M.B., and Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease. The Zutphen elderly study. Lancet 342 (1993) 1007-1011
10. Hirata K., Shimada K., Watanabe H., Otsuka R., Tokai K., et al. Black tea increases coronary flow rate velocity reserve in healthy male subjects. Am. J. Cardiol. 93 (2004) 1384-1388
11. Hsieh Y.H., Kuo P.M., Chien S.C., Shyur L.F., and Wang S.Y. Effects of Chamaecyparis formosensis Matasumura extractivities on lipopolysaccharide-induced release of nitric oxide. Phytomedicine 14 (2007) 675-680
12. Hwang B.Y., Lee J.H., Koo T.H., Hong Y.S., Ro I.S., Lee K.S., and Lee J.J. Furanoligularenone, an eremophilane from Ligularia fischerri inhibits the lipopolysaccharide-induced production of nitric oxide and prostaglandin E2 in macrophage RAW264.7 cells. Planta. Med. (2002) 68: 101-105
13. Joyce D.A., and Steer J.H. Differentiation of U937 promonocytic cell line induced by phorbol myristate acetate or retinoic acid: effect of aurothiomalate. Agents Actions 37 (1992) 305-310
14. Keefer L.K., and Wink D. DNA damage and nitric oxide. Adv. Exp. Med. Biol. 387 (1996) 177-185
15. Knept P., Kumpulainen J., Javinen R., Rissanen H., Heliovaara A., Reunanen A., Hakulinen T., and Aromaa A. Flavonoid intake and the risk of chronic diseases. Am. J. Clin. Nutr. 76 (2002) 478-481
16. Kuwano K., Hagimoto N., and Nakanishi Y. The role of apoptosis in pulmonary. Histol. Histopath. 19 (2004) 867-881
17. Lee-Hitz Y.Y., Boerboom A.J., Westphal A.H., van-Berkel W.J., Aarts J.M., and Reirjens I.M. Pro-oxidant activity of flavonoids induces EpRE-mediated gene expression. Chem. Res. Toxicol. 19 (2006) 1499-1505
18. Lin Y.L., Tsai S.H., Lin-Shiau S.Y., Ho C.T., and Lin J.K. Theaflavin-3, 3′-from black tea blocks the nitric oxide down regulating the activation of NF-kappaB in macrophages. Eur. J. Pharmacol. 367 (1999) 379-388
19. Ludwig A., Lorenz M., Stenile F., Meiners S., et al. The tea flavonoids epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells. Biochem. Biophys. Res. Commun. 316 (2004) 619-665
20. Manach C., Scalbert A., Morand C., Remesy C., and Jimenez L. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 79 (2004) 727-747
21. Meng F., and Lowell C.A. Lipopolysaccharide-induced macrophage activation and signal transduction in the absence of Src family kinases Hck, Fgr, and Lyn. J. Exp. Med. 189 (1997) 1661-1670
22. Roitt I., Brostoff J., and Male D. Hypersensitivity-type III. Immunology. sixth ed. (2002), Moshby 357-368
23. 2-induced chromosomal damage to WIL2-NS cells. Biosci. Biotechnol. Biochem. 68 (2004) 271-276
24. Scalbert A., Manach C., Morand C., Remesy C., and Jimenez L. Dietary flavonoids and the prevention of diseases. Crit. Rev. Food Sci. Nutr. 45 (2005) 287-306
25. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keun Y.S., Park K.K., and Lee S.S. Molecular mechanisms underlying chemoprotective activities of anti-inflammatory phytochemicals; down regulation of cox-2, and iNOS through suppression of NF-kB activation. Mutat. Res. 480 (2001) 243-268
26. Tamir S., and Tannenbaum S.R. The role of nitric oxide (NO) in the carcinogenesis process. Biochim. Biophys. Acta 1288 (1996) F31-F36